88 related articles for article (PubMed ID: 35290436)
1. RNA Helicase DHX37 Facilitates Liver Cancer Progression by Cooperating with PLRG1 to Drive Superenhancer-Mediated Transcription of Cyclin D1.
Liu Z; Ye Y; Liu Y; Liu Y; Chen H; Shen M; Wang Z; Huang S; Han L; Chen Z; He X
Cancer Res; 2022 May; 82(10):1937-1952. PubMed ID: 35290436
[TBL] [Abstract][Full Text] [Related]
2. Elevated level of PLRG1 is critical for the proliferation and maintenance of genome stability of tumor cells.
Choi H; Kang M; Lee KH; Kim YS
BMB Rep; 2023 Nov; 56(11):612-617. PubMed ID: 37817442
[TBL] [Abstract][Full Text] [Related]
3. CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1.
Liao J; Chen Z; Chang R; Yuan T; Li G; Zhu C; Wen J; Wei Y; Huang Z; Ding Z; Chu L; Liang J; Zhang B
Int J Biol Sci; 2023; 19(16):5218-5232. PubMed ID: 37928273
[TBL] [Abstract][Full Text] [Related]
4. DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC.
Liu N; Zhang H; Zhang C; Li Z; Huang L; Sun J; Qi J; Deng X; Huang N; Mu Y; Li Z; Tian H
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958405
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Superenhancer-Driven LncRNA FASRL by USF1 Promotes De Novo Fatty Acid Biosynthesis to Exacerbate Hepatocellular Carcinoma.
Peng JY; Cai DK; Zeng RL; Zhang CY; Li GC; Chen SF; Yuan XQ; Peng L
Adv Sci (Weinh); 2022 Oct; 10(1):e2204711. PubMed ID: 36307901
[TBL] [Abstract][Full Text] [Related]
6. DHX37 and the implications in Disorders of Sex Development: an update review.
de Oliveira FR; Guaragna MS; Maciel-Guerra AT; Barros BA; de Mello MP; Guerra-Junior G; Fabbri-Scallet H
Horm Res Paediatr; 2023 Dec; ():. PubMed ID: 38142677
[TBL] [Abstract][Full Text] [Related]
7. Mechanical force modulates macrophage proliferation via Piezo1-AKT-Cyclin D1 axis.
Xu H; Guan J; Jin Z; Yin C; Wu S; Sun W; Zhang H; Yan B
FASEB J; 2022 Aug; 36(8):e22423. PubMed ID: 35775626
[TBL] [Abstract][Full Text] [Related]
8. CCND1-Induced Autophagy Contributes to Lymph Node Metastasis in Endometrial Cancer.
Su Y; Zhou H; Ma Z; Liu J; Li C
Horm Metab Res; 2023 Jun; 55(6):413-419. PubMed ID: 37019147
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical Overexpression of Cyclin D1 in Tunisian Invasive Breast Carcinoma Women.
Bouzidi L; Makni S; Feki J; Kallel R; Graja S; Gouiaa N; Sellami-Boudawara T; Mellouli M
Arch Iran Med; 2022 Apr; 25(4):250-256. PubMed ID: 35942997
[TBL] [Abstract][Full Text] [Related]
10. RNA Helicase DDX24 Stabilizes LAMB1 to Promote Hepatocellular Carcinoma Progression.
Liu T; Gan H; He S; Deng J; Hu X; Li L; Cai L; He J; Long H; Cai J; Li H; Zhang Q; Wang L; Chen F; Chen Y; Zhang H; Li J; Yang L; Liu Y; Yang JH; Kuang DM; Pang P; He H; Shan H
Cancer Res; 2022 Sep; 82(17):3074-3087. PubMed ID: 35763670
[TBL] [Abstract][Full Text] [Related]
11. Wnt Signaling Stimulates Cooperation between GREB1 and HNF4α to Promote Proliferation in Hepatocellular Carcinoma.
Matsumoto S; Harada A; Seta M; Akita M; Gon H; Fukumoto T; Kikuchi A
Cancer Res; 2023 Jul; 83(14):2312-2327. PubMed ID: 37347203
[TBL] [Abstract][Full Text] [Related]
12. Role of cyclin D1 in glial tumors-A retrospective and observational study.
Mehta R; Yadav R; Vatsgotra R
Indian J Pathol Microbiol; 2023; 66(2):264-268. PubMed ID: 37077066
[TBL] [Abstract][Full Text] [Related]
13. Gain of CCND1 May Occur Too Infrequently in Cutaneous Melanoma, and Too Late in Melanomagenesis, to Be Diagnostically Useful: Genomic Analysis of 88 Cases.
McFadden JR; Chaudhari AS; Stevanovic M; Tsongalis GJ; Hughes EG; Sriharan A
Am J Dermatopathol; 2023 May; 45(5):311-319. PubMed ID: 36939129
[TBL] [Abstract][Full Text] [Related]
14. Synthetic lethal interactions of DEAD/H-box helicases as targets for cancer therapy.
Arna AB; Patel H; Singh RS; Vizeacoumar FS; Kusalik A; Freywald A; Vizeacoumar FJ; Wu Y
Front Oncol; 2022; 12():1087989. PubMed ID: 36761420
[TBL] [Abstract][Full Text] [Related]
15. m
Bian Y; Wang Y; Xu S; Gao Z; Li C; Fan Z; Ding J; Wang K
Cells; 2022 Sep; 11(19):. PubMed ID: 36230970
[TBL] [Abstract][Full Text] [Related]
16. Development of Olaparib-Resistance Prostate Cancer Cell Lines to Identify Mechanisms Associated with Acquired Resistance.
Cahuzac M; Péant B; Mes-Masson AM; Saad F
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010871
[TBL] [Abstract][Full Text] [Related]
17. DDTC Suppresses Ovarian Cancer Development via the PI3K/AKT/mTOR Signaling Pathway.
Li M; Zhang W; Wang Y; Huang K; Sun T; Qiu Z; Yang L; Wu M; Zhang X; Zhang W
Dis Markers; 2022; 2022():1941077. PubMed ID: 35978887
[TBL] [Abstract][Full Text] [Related]
18. CCND1 Copy Number Variation in Circulating Tumor DNA from Luminal B Breast Cancer Patients.
Shimazaki A; Kubo M; Kurata K; Takao Y; Hayashi S; Harada Y; Kawaji H; Kaneshiro K; Yamada M; Kai M; Nakamura M
Anticancer Res; 2022 Aug; 42(8):4071-4077. PubMed ID: 35896251
[TBL] [Abstract][Full Text] [Related]
19.
Liu J; Lin J; Wang X; Zheng X; Gao X; Huang Y; Chen G; Xiong J; Lan B; Chen C; Si L; Chen Y
Front Immunol; 2022; 13():725679. PubMed ID: 35844619
[TBL] [Abstract][Full Text] [Related]
20. CCND1 Amplification in Breast Cancer -associations With Proliferation, Histopathological Grade, Molecular Subtype and Prognosis.
Valla M; Klæstad E; Ytterhus B; Bofin AM
J Mammary Gland Biol Neoplasia; 2022 Mar; 27(1):67-77. PubMed ID: 35459982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
